[ORGANIZATION]
CRISPR Therapeutics
Featured in 3 tracked stories · first seen
Situations
FDA review of Grail Galleri cancer blood test
2 clusters · 2 sources · last updated
Latest: Biotech firms Grail and CRISPR Therapeutics see regulatory developments
The U.S. Food and Drug Administration (FDA) has scheduled an advisory committee meeting for September 23, 2026, to review the premarket approval application for Grail Inc.’s Galleri multi-cancer early detection (MCED) bl
Biotechnology sector market volatility
2 clusters · 5 sources · last updated
Latest: Market Update: Costco, Xencor, and various biotech firms report earnings and stock shifts
The biotechnology sector experienced notable stock price volatility and varied financial reporting in late August 2026. Initially, Recursion Pharmaceuticals and CRISPR Therapeutics saw significant share price gains, wit
Also covered in
-
Archer Aviation and CRISPR Therapeutics Highlighted as Top Mid‑Cap Growth Picks
[BUSINESS] · 2 sources ·